InsiderTrades

Form 4 for HCA HCA Healthcare

Accepted 2024-05-20 00:00:00 ET · period of report 2024-05-16 · accession 0001209191-24-005677 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-20 2024-05-16 HCA Whalen Kathleen M SVP, Chief Ethics Off S - Sale+OE $326.30 -3,204 9,454 -25% -$1.05M
D 2024-05-20 2024-05-17 HCA Whalen Kathleen M SVP, Chief Ethics Off F - Tax $322.86 -2,861 11.3K -20% -$923.7K
DM 2024-05-20 2024-05-17 HCA Whalen Kathleen M SVP, Chief Ethics Off M - OptEx $112.70 +4,725 12.5K +61% +$532.5K
DM 2024-05-20 2024-05-17 HCA Whalen Kathleen M SVP, Chief Ethics Off M - OptEx $0.00 -4,725 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-16 S D 3,204 $326.30 9,454 D — —
2 Common Common Stock 2024-05-17 F D 2,861 $322.86 11,318 D — —
3 Common Common Stock 2024-05-17 M A 1,685 $133.53 14,179 D — —
4 Common Common Stock 2024-05-17 M A 3,040 $101.16 12,494 D — —
5 Derivative Stock Appreciation Right 2024-05-17 M D 1,685 $0.00 12,045 D $133.53 · — to 2028-10-31 1,685 Common Stock (F2) The stock appreciation rights vested in four equal annual installments beginning on October 31, 2019.
6 Derivative Stock Appreciation Right 2024-05-17 M D 3,040 $0.00 0 D $101.16 · — to 2028-01-31 3,040 Common Stock (F1) The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.